ZURICH (Reuters) – Novartis’s foray into digital technology intensified on Wednesday as the Swiss drugmaker launched a mobile-phone based app to help collect data from people participating in eye disease studies.
Source: Reuters Medical News
This article explores how practices can ensure their defences are up to the challenge of any future cyber-attacks
Related items from OnMedica NHS cyber-attack was ‘inevitable’ given poor investment |
Source: OnMedica